<code id='345486288D'></code><style id='345486288D'></style>
    • <acronym id='345486288D'></acronym>
      <center id='345486288D'><center id='345486288D'><tfoot id='345486288D'></tfoot></center><abbr id='345486288D'><dir id='345486288D'><tfoot id='345486288D'></tfoot><noframes id='345486288D'>

    • <optgroup id='345486288D'><strike id='345486288D'><sup id='345486288D'></sup></strike><code id='345486288D'></code></optgroup>
        1. <b id='345486288D'><label id='345486288D'><select id='345486288D'><dt id='345486288D'><span id='345486288D'></span></dt></select></label></b><u id='345486288D'></u>
          <i id='345486288D'><strike id='345486288D'><tt id='345486288D'><pre id='345486288D'></pre></tt></strike></i>

          explore

          explore

          author:explore    Page View:2867
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

          advertisement

          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more
          Biogen walks away from Aduhelm, years after polarizing approval
          Biogen walks away from Aduhelm, years after polarizing approval

          JessicaRinaldi/TheBostonGlobeBiogenisgivingupitsownershipofAduhelm,theAlzheimer’sdiseasetreatmentwho

          read more
          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more

          Vertex non

          ScientistsChristinaFreyandPaulNegulescuworkinalabatVertexPharmaceuticalsinSanDiego.SandyHuffakerforS